Nelson, K, Holmes, LB. Malformations due to presumed mutations in new born
infants. N Engl J Med
Headley, J, Northstone, K, Simmons, H, Golding, J, and the ALSPAC study team.
Medication use during pregnancy: data from the Avon
longitudinal study of parents and children. Eur J
2004; 60: 355–61.
Omtzigt, J. Prenatal diagnosis of spina bifida aperta after
first trimester valproate exposure. Prenatal
1992; 12: 893–7.
James, L, Barnes, TRE, Lelliott, P, Taylor, D, Paton, C. Informing patients of the teratogenic potential of
mood stabilizing drugs: a case note review of the practice of
psychiatrists. J Psychopharmacol
2007; 21: 815–9.
Newham, JJ, Thomas, SH, MacRitchie, K, McElhatton, PR, McAlliser-Williams, RH. Birth weight of infants after maternal exposure to
typical and atypical antipsychotics. A prospective comparison
study. Br J Psychiatry
2008; 192: 333–7.
Allison, DB, Mentore, JL, Heo, M, Chandler, LP, Cappelleri, JC, Infante, MC, Weiden, PJ. Antipsychotic-induced weigh gain: a comprehensive
research synthesis. Am J Psychiatry
1999; 156: 1686–96.
Ebenbichler, CF, Laimer, M, Eder, U, Mangweth, B, Weiss, E, Hofer, A, Hummer, M, Kemmler, G, Lechleitner, M, Patsch, JR, Fleischhacker, WW. Olanzapine induces insulin resistance: results from
a prospective study. J Clin Psychiatry
2003; 64: 1436–9.
Diav-Citrin, O, Schechtman, S, Weinbaum, D, Arnon, J, Di Gianantonio, E, Clementi, C, Ornoy, A. Paroxetine and fluoxetine in pregnancy: a
multicentre, prospective, controlled study.
2005; 20: 459.
Alwan, S, Reefhuis, J, Rasmussen, SA, Olney, RS, Friedman, JM. Use of selective serotonin re-uptake inhibitors in
pregnancy and the risk of birth defects. N Engl J
2007; 356: 2684–92.
Louik, C, Lin, AE, Werler, MM, Hernandez-Diaz, S, Mitchell, AA. First-trimester use of selective serotonin reuptake
inhibitors and the risk of birth defects. N Engl
2007; 356: 2675–83.
Ramos, E, At-Andre, M, Roy, E, Oraichi, D, Berand, A. Duration of antidepressant use during pregnancy and
risk of major congenital malformations. Br J
2008; 192: 344–50.
Oberlander, TF, Warburton, W, Misri, S, Aghajanian, J, Hertzman, C. Effects of timing and duration of gestational
exposure to selective serotonin reuptake inhibitors: population-based
study. Br J Psychiatry
2008; 192: 338–43.
McKenna, K, Koren, G, Tetelbaum, M, Wilton, L, Shakir, S, Diav-Citrin, O, Levinson, A, Zipursky, RB, Einarson, A. Pregnancy outcome of women using atypical
antipsychotic drugs: a prospective comparative study.
J Clin Psychiatry
2005; 66: 444–9.